Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenue	$ 46,098	$ 49,537	$ 131,719	$ 145,776
Cost of Revenue, excluding depreciation and amortization stated below	39,936	41,874	114,432	123,600
Gross Profit	6,162	7,663	17,287	22,176
Operating Expenses:
Selling, general and administrative expenses	6,996	8,641	20,023	24,110
Depreciation and amortization	474	513	1,427	1,388
Total Operating Expenses	7,470	9,154	21,450	25,498
Net Loss From Continuing Operations	(1,308)	(1,491)	(4,163)	(3,322)
Other Expenses:
Interest expense	(487)	(1,197)	(2,954)	(3,338)
Amortization of debt discount and deferred financing costs	(87)	(119)	(347)	(320)
Other (loss) income, net	(911)	(237)	(656)	(63)
Total Other Expenses, net	(1,485)	(1,553)	(3,957)	(3,721)
Net Operating Loss	(2,793)	(3,044)	(8,120)	(7,043)
Discontinued Operations		(1,190)	901	(2,879)
Loss Before Benefit from Income Tax	(2,793)	(4,234)	(7,219)	(9,922)
Provision from Income taxes	(51)	(21)	(151)	(67)
Net Loss	(2,844)	(4,255)	(7,370)	(9,989)
Net Loss Attributable to Common Stockholders	$ (2,844)	$ (4,255)	$ (7,370)	$ (9,989)
Net Operating Loss Attributable to Common Stockholders - Basic	$ (3.22)	$ (7.05)	$ (11.19)	$ (18.71)
Net Income (Loss) from Discontinued Operations Attributable to Common Stockholders - Basic		$ (2.74)	$ 1.22	$ (7.58)
Weighted Average Shares Outstanding – Basic	884,564	434,959	739,336	380,038
Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]
Net Loss Attributable to Common Stockholders - Diluted	$ (2,844)	$ (3,065)	$ (8,271)	$ (7,110)
Net Operating Loss Attributable to Common Stockholders - Diluted	$ (3.22)	$ (7.05)	$ (11.19)	$ (18.71)
Net Income (Loss) from Discontinued Operations Attributable to Common Stockholders - Diluted		$ (2.74)	$ 1.22	$ (7.58)
Weighted Average Shares Outstanding – Diluted	884,564	434,959	739,336	380,038